ES2329012T3 - Receptor del factor de necrosis tumoral humano. - Google Patents

Info

Publication number

ES2329012T3

ES2329012T3 ES01990899T ES01990899T ES2329012T3 ES 2329012 T3 ES2329012 T3 ES 2329012T3 ES 01990899 T ES01990899 T ES 01990899T ES 01990899 T ES01990899 T ES 01990899T ES 2329012 T3 ES2329012 T3 ES 2329012T3

Authority

ES

Spain

Prior art keywords

ztnfr12

seq

amino acid

polypeptide

antibody

Prior art date

2000-11-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Lifetime

Links

• Espacenet
• Global Dossier
• Discuss

• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 title abstract 2
• 102000057041 human TNF Human genes 0.000 title abstract 2
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 373
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 339
• 229920001184 polypeptide Polymers 0.000 claims description 314
• 238000000034 method Methods 0.000 claims description 209
• 210000004027 cell Anatomy 0.000 claims description 178
• 125000000539 amino acid group Chemical group 0.000 claims description 141
• 125000003729 nucleotide group Chemical group 0.000 claims description 135
• 239000002773 nucleotide Substances 0.000 claims description 132
• 150000007523 nucleic acids Chemical class 0.000 claims description 128
• 102000039446 nucleic acids Human genes 0.000 claims description 126
• 108020004707 nucleic acids Proteins 0.000 claims description 126
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 115
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 93
• 108020001507 fusion proteins Proteins 0.000 claims description 81
• 102000037865 fusion proteins Human genes 0.000 claims description 80
• 108060003951 Immunoglobulin Proteins 0.000 claims description 47
• 102000018358 immunoglobulin Human genes 0.000 claims description 47
• 239000013598 vector Substances 0.000 claims description 40
• 239000013604 expression vector Substances 0.000 claims description 33
• 239000002253 acid Substances 0.000 claims description 23
• 238000013518 transcription Methods 0.000 claims description 23
• 230000035897 transcription Effects 0.000 claims description 23
• 230000001580 bacterial effect Effects 0.000 claims description 10
• 241000238631 Hexapoda Species 0.000 claims description 9
• 241000271566 Aves Species 0.000 claims description 5
• 238000012258 culturing Methods 0.000 claims description 5
• 230000002538 fungal effect Effects 0.000 claims description 4
• 235000013311 vegetables Nutrition 0.000 claims description 3
• 210000005253 yeast cell Anatomy 0.000 claims description 3
• 102000005962 receptors Human genes 0.000 abstract description 55
• 108020003175 receptors Proteins 0.000 abstract description 55
• 239000003814 drug Substances 0.000 abstract description 14
• 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract description 7
• 238000011160 research Methods 0.000 abstract description 3
• 102000003390 tumor necrosis factor Human genes 0.000 abstract description 2
• 108090000623 proteins and genes Proteins 0.000 description 315
• 102000004169 proteins and genes Human genes 0.000 description 157
• 235000018102 proteins Nutrition 0.000 description 151
• 150000001413 amino acids Chemical class 0.000 description 138
• 235000001014 amino acid Nutrition 0.000 description 137
• 229940024606 amino acid Drugs 0.000 description 118
• 102000053602 DNA Human genes 0.000 description 96
• 108020004414 DNA Proteins 0.000 description 96
• 230000014509 gene expression Effects 0.000 description 92
• 241000282414 Homo sapiens Species 0.000 description 73
• 239000000523 sample Substances 0.000 description 71
• 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 64
• 230000027455 binding Effects 0.000 description 63
• 239000012634 fragment Substances 0.000 description 62
• 101100537522 Homo sapiens TNFSF13B gene Proteins 0.000 description 61
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 49
• 238000003752 polymerase chain reaction Methods 0.000 description 48
• 108020004635 Complementary DNA Proteins 0.000 description 46
• 230000000295 complement effect Effects 0.000 description 44
• 239000000203 mixture Substances 0.000 description 43
• 238000010804 cDNA synthesis Methods 0.000 description 41
• 239000002299 complementary DNA Substances 0.000 description 41
• 230000035772 mutation Effects 0.000 description 39
• 238000009396 hybridization Methods 0.000 description 37
• 239000003446 ligand Substances 0.000 description 36
• 238000004458 analytical method Methods 0.000 description 35
• 238000013459 approach Methods 0.000 description 33
• 239000003550 marker Substances 0.000 description 33
• 238000006467 substitution reaction Methods 0.000 description 33
• 210000003719 b-lymphocyte Anatomy 0.000 description 32
• 230000000694 effects Effects 0.000 description 32
• 241000699670 Mus sp. Species 0.000 description 31
• 238000004519 manufacturing process Methods 0.000 description 31
• 108020004705 Codon Proteins 0.000 description 29
• 102000040430 polynucleotide Human genes 0.000 description 29
• 108091033319 polynucleotide Proteins 0.000 description 29
• 239000002157 polynucleotide Substances 0.000 description 29
• 108020004999 messenger RNA Proteins 0.000 description 28
• 210000001519 tissue Anatomy 0.000 description 28
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 27
• 108091028043 Nucleic acid sequence Proteins 0.000 description 26
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 25
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 25
• 239000000427 antigen Substances 0.000 description 25
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
• 108091007433 antigens Proteins 0.000 description 24
• 102000036639 antigens Human genes 0.000 description 24
• 230000005856 abnormality Effects 0.000 description 22
• 239000002585 base Substances 0.000 description 22
• 201000010099 disease Diseases 0.000 description 22
• 241000894007 species Species 0.000 description 22
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 21
• 239000012472 biological sample Substances 0.000 description 21
• 229920001223 polyethylene glycol Polymers 0.000 description 21
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 20
• 238000010367 cloning Methods 0.000 description 20
• 230000001105 regulatory effect Effects 0.000 description 20
• 239000000243 solution Substances 0.000 description 20
• 239000002202 Polyethylene glycol Substances 0.000 description 19
• 239000000047 product Substances 0.000 description 19
• 230000003248 secreting effect Effects 0.000 description 19
• 241000588724 Escherichia coli Species 0.000 description 18
• 210000000349 chromosome Anatomy 0.000 description 18
• 230000004927 fusion Effects 0.000 description 18
• 229920000642 polymer Polymers 0.000 description 18
• 108010076504 Protein Sorting Signals Proteins 0.000 description 17
• 230000003302 anti-idiotype Effects 0.000 description 17
• 230000000890 antigenic effect Effects 0.000 description 17
• 238000001514 detection method Methods 0.000 description 17
• 238000000746 purification Methods 0.000 description 17
• 238000011282 treatment Methods 0.000 description 17
• 241001529936 Murinae Species 0.000 description 16
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 16
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
• 238000006243 chemical reaction Methods 0.000 description 15
• 239000013615 primer Substances 0.000 description 15
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 14
• -1 carbocyclic carbohydrate Chemical class 0.000 description 14
• 150000001720 carbohydrates Chemical class 0.000 description 14
• 235000014633 carbohydrates Nutrition 0.000 description 14
• 238000012360 testing method Methods 0.000 description 14
• 241000701447 unidentified baculovirus Species 0.000 description 14
• 238000005406 washing Methods 0.000 description 14
• 230000037430 deletion Effects 0.000 description 13
• 238000012217 deletion Methods 0.000 description 13
• 229940027941 immunoglobulin g Drugs 0.000 description 13
• 206010028417 myasthenia gravis Diseases 0.000 description 13
• 210000002966 serum Anatomy 0.000 description 13
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
• 206010025323 Lymphomas Diseases 0.000 description 12
• 206010028980 Neoplasm Diseases 0.000 description 12
• 238000003556 assay Methods 0.000 description 12
• 238000003776 cleavage reaction Methods 0.000 description 12
• 238000005516 engineering process Methods 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 229940127121 immunoconjugate Drugs 0.000 description 12
• 238000012216 screening Methods 0.000 description 12
• 239000000126 substance Substances 0.000 description 12
• 238000012546 transfer Methods 0.000 description 12
• 230000014616 translation Effects 0.000 description 12
• 239000003981 vehicle Substances 0.000 description 12
• 102000004127 Cytokines Human genes 0.000 description 11
• 108090000695 Cytokines Proteins 0.000 description 11
• 108090000790 Enzymes Proteins 0.000 description 11
• 241001465754 Metazoa Species 0.000 description 11
• 241001452677 Ogataea methanolica Species 0.000 description 11
• 108091034117 Oligonucleotide Proteins 0.000 description 11
• 210000001744 T-lymphocyte Anatomy 0.000 description 11
• 230000015572 biosynthetic process Effects 0.000 description 11
• 239000003795 chemical substances by application Substances 0.000 description 11
• 150000001875 compounds Chemical class 0.000 description 11
• 229940088598 enzyme Drugs 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 230000003834 intracellular effect Effects 0.000 description 11
• 230000001404 mediated effect Effects 0.000 description 11
• 239000012528 membrane Substances 0.000 description 11
• 210000004379 membrane Anatomy 0.000 description 11
• 230000007017 scission Effects 0.000 description 11
• 125000006850 spacer group Chemical group 0.000 description 11
• 108010009685 Cholinergic Receptors Proteins 0.000 description 10
• 241000196324 Embryophyta Species 0.000 description 10
• 102000004190 Enzymes Human genes 0.000 description 10
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 10
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 10
• 102000034337 acetylcholine receptors Human genes 0.000 description 10
• 230000004913 activation Effects 0.000 description 10
• 210000004369 blood Anatomy 0.000 description 10
• 239000008280 blood Substances 0.000 description 10
• 238000007901 in situ hybridization Methods 0.000 description 10
• 210000004962 mammalian cell Anatomy 0.000 description 10
• 239000013612 plasmid Substances 0.000 description 10
• 238000002360 preparation method Methods 0.000 description 10
• 230000002285 radioactive effect Effects 0.000 description 10
• 238000013519 translation Methods 0.000 description 10
• 239000000872 buffer Substances 0.000 description 9
• 230000029087 digestion Effects 0.000 description 9
• 239000000539 dimer Substances 0.000 description 9
• 230000002068 genetic effect Effects 0.000 description 9
• 238000002703 mutagenesis Methods 0.000 description 9
• 231100000350 mutagenesis Toxicity 0.000 description 9
• 230000006320 pegylation Effects 0.000 description 9
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 9
• 230000002103 transcriptional effect Effects 0.000 description 9
• 208000023275 Autoimmune disease Diseases 0.000 description 8
• 108010050904 Interferons Proteins 0.000 description 8
• 102000014150 Interferons Human genes 0.000 description 8
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 230000004075 alteration Effects 0.000 description 8
• 230000008901 benefit Effects 0.000 description 8
• 229960002685 biotin Drugs 0.000 description 8
• 239000011616 biotin Substances 0.000 description 8
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
• 239000003153 chemical reaction reagent Substances 0.000 description 8
• TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 8
• 230000000984 immunochemical effect Effects 0.000 description 8
• 229940072221 immunoglobulins Drugs 0.000 description 8
• 239000007924 injection Substances 0.000 description 8
• 238000002347 injection Methods 0.000 description 8
• 230000037431 insertion Effects 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 230000003993 interaction Effects 0.000 description 8
• 239000002853 nucleic acid probe Substances 0.000 description 8
• 230000004044 response Effects 0.000 description 8
• 238000003786 synthesis reaction Methods 0.000 description 8
• 230000001225 therapeutic effect Effects 0.000 description 8
• 229920003169 water-soluble polymer Polymers 0.000 description 8
• 241000699666 Mus <mouse, genus> Species 0.000 description 7
• 206010035226 Plasma cell myeloma Diseases 0.000 description 7
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 7
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
• 238000005917 acylation reaction Methods 0.000 description 7
• 239000002671 adjuvant Substances 0.000 description 7
• 239000000556 agonist Substances 0.000 description 7
• 239000005557 antagonist Substances 0.000 description 7
• 201000011510 cancer Diseases 0.000 description 7
• 238000010276 construction Methods 0.000 description 7
• 238000003745 diagnosis Methods 0.000 description 7
• 230000002255 enzymatic effect Effects 0.000 description 7
• 150000002148 esters Chemical class 0.000 description 7
• 210000004408 hybridoma Anatomy 0.000 description 7
• 230000001965 increasing effect Effects 0.000 description 7
• 210000003292 kidney cell Anatomy 0.000 description 7
• 210000002414 leg Anatomy 0.000 description 7
• 210000001165 lymph node Anatomy 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• 239000011159 matrix material Substances 0.000 description 7
• TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 7
• 239000000758 substrate Substances 0.000 description 7
• 229940124597 therapeutic agent Drugs 0.000 description 7
• 238000002560 therapeutic procedure Methods 0.000 description 7
• 125000003396 thiol group Chemical group [H]S* 0.000 description 7
• 241001515965 unidentified phage Species 0.000 description 7
• 101100369999 Homo sapiens TNFSF13 gene Proteins 0.000 description 6
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• 102100024585 Tumor necrosis factor ligand superfamily member 13 Human genes 0.000 description 6
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
• 230000003321 amplification Effects 0.000 description 6
• 230000002391 anti-complement effect Effects 0.000 description 6
• 108010008730 anticomplement Proteins 0.000 description 6
• 235000020958 biotin Nutrition 0.000 description 6
• 230000008859 change Effects 0.000 description 6
• 230000007423 decrease Effects 0.000 description 6
• 238000013461 design Methods 0.000 description 6
• 229940079593 drug Drugs 0.000 description 6
• 239000012636 effector Substances 0.000 description 6
• 235000018977 lysine Nutrition 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 238000010172 mouse model Methods 0.000 description 6
• 210000003205 muscle Anatomy 0.000 description 6
• 238000003199 nucleic acid amplification method Methods 0.000 description 6
• 229920005989 resin Polymers 0.000 description 6
• 239000011347 resin Substances 0.000 description 6
• 239000007790 solid phase Substances 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 210000004881 tumor cell Anatomy 0.000 description 6
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 6
• 241000701161 unidentified adenovirus Species 0.000 description 6
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 5
• 108700024394 Exon Proteins 0.000 description 5
• 208000009386 Experimental Arthritis Diseases 0.000 description 5
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
• 239000004472 Lysine Substances 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
• 150000007513 acids Chemical class 0.000 description 5
• 230000010933 acylation Effects 0.000 description 5
• 150000001299 aldehydes Chemical class 0.000 description 5
• 238000005804 alkylation reaction Methods 0.000 description 5
• 210000004899 c-terminal region Anatomy 0.000 description 5
• 230000036755 cellular response Effects 0.000 description 5
• 238000004587 chromatography analysis Methods 0.000 description 5
• 238000007796 conventional method Methods 0.000 description 5
• 238000002405 diagnostic procedure Methods 0.000 description 5
• 238000004520 electroporation Methods 0.000 description 5
• 210000003527 eukaryotic cell Anatomy 0.000 description 5
• 238000010353 genetic engineering Methods 0.000 description 5
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
• 239000002955 immunomodulating agent Substances 0.000 description 5
• 229940121354 immunomodulator Drugs 0.000 description 5
• 238000000099 in vitro assay Methods 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 238000011534 incubation Methods 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 229940079322 interferon Drugs 0.000 description 5
• 238000002955 isolation Methods 0.000 description 5
• 239000006166 lysate Substances 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 239000011734 sodium Substances 0.000 description 5
• 210000002700 urine Anatomy 0.000 description 5
• 108090001008 Avidin Proteins 0.000 description 4
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 4
• 208000003950 B-cell lymphoma Diseases 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
• 108090000994 Catalytic RNA Proteins 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 108010035532 Collagen Proteins 0.000 description 4
• 102000008186 Collagen Human genes 0.000 description 4
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
• 206010018364 Glomerulonephritis Diseases 0.000 description 4
• 102100025594 Guided entry of tail-anchored proteins factor CAMLG Human genes 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101000932902 Homo sapiens Guided entry of tail-anchored proteins factor CAMLG Proteins 0.000 description 4
• 206010062016 Immunosuppression Diseases 0.000 description 4
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 4
• 102000057297 Pepsin A Human genes 0.000 description 4
• 108090000284 Pepsin A Proteins 0.000 description 4
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• 238000002105 Southern blotting Methods 0.000 description 4
• 206010042674 Swelling Diseases 0.000 description 4
• 108020004566 Transfer RNA Proteins 0.000 description 4
• 238000001042 affinity chromatography Methods 0.000 description 4
• 150000001412 amines Chemical class 0.000 description 4
• 125000003277 amino group Chemical group 0.000 description 4
• 230000037396 body weight Effects 0.000 description 4
• 229940098773 bovine serum albumin Drugs 0.000 description 4
• 230000003197 catalytic effect Effects 0.000 description 4
• 239000002738 chelating agent Substances 0.000 description 4
• 239000003638 chemical reducing agent Substances 0.000 description 4
• 230000002759 chromosomal effect Effects 0.000 description 4
• 229920001436 collagen Polymers 0.000 description 4
• 238000005520 cutting process Methods 0.000 description 4
• 231100000433 cytotoxic Toxicity 0.000 description 4
• 230000001472 cytotoxic effect Effects 0.000 description 4
• 239000007850 fluorescent dye Substances 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• 238000007429 general method Methods 0.000 description 4
• 230000003053 immunization Effects 0.000 description 4
• 238000003018 immunoassay Methods 0.000 description 4
• 230000002163 immunogen Effects 0.000 description 4
• 230000002584 immunomodulator Effects 0.000 description 4
• 230000001506 immunosuppresive effect Effects 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 230000000977 initiatory effect Effects 0.000 description 4
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 4
• 229920002521 macromolecule Polymers 0.000 description 4
• 230000005291 magnetic effect Effects 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 239000000178 monomer Substances 0.000 description 4
• 201000000050 myeloid neoplasm Diseases 0.000 description 4
• 230000036961 partial effect Effects 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 229940111202 pepsin Drugs 0.000 description 4
• 238000010647 peptide synthesis reaction Methods 0.000 description 4
• 238000002823 phage display Methods 0.000 description 4
• 239000013600 plasmid vector Substances 0.000 description 4
• 102000054765 polymorphisms of proteins Human genes 0.000 description 4
• 239000002987 primer (paints) Substances 0.000 description 4
• 201000001474 proteinuria Diseases 0.000 description 4
• 238000005932 reductive alkylation reaction Methods 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 210000000952 spleen Anatomy 0.000 description 4
• 230000002269 spontaneous effect Effects 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• 230000008961 swelling Effects 0.000 description 4
• 239000013638 trimer Substances 0.000 description 4
• 230000003612 virological effect Effects 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 3
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 3
• 229920000936 Agarose Polymers 0.000 description 3
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 3
• 208000034172 Autoimmune Experimental Myasthenia Gravis Diseases 0.000 description 3
• 235000014469 Bacillus subtilis Nutrition 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 208000011691 Burkitt lymphomas Diseases 0.000 description 3
• 102100035882 Catalase Human genes 0.000 description 3
• 108010053835 Catalase Proteins 0.000 description 3
• 102000053642 Catalytic RNA Human genes 0.000 description 3
• 241000699800 Cricetinae Species 0.000 description 3
• 239000003155 DNA primer Substances 0.000 description 3
• 229920002307 Dextran Polymers 0.000 description 3
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
• KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 3
• 102000005720 Glutathione transferase Human genes 0.000 description 3
• 108010070675 Glutathione transferase Proteins 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 108091092195 Intron Proteins 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 3
• 208000034578 Multiple myelomas Diseases 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• 206010028372 Muscular weakness Diseases 0.000 description 3
• 238000005481 NMR spectroscopy Methods 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 241000288906 Primates Species 0.000 description 3
• 108091034057 RNA (poly(A)) Proteins 0.000 description 3
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
• 208000001647 Renal Insufficiency Diseases 0.000 description 3
• 241000283984 Rodentia Species 0.000 description 3
• 229920002684 Sepharose Polymers 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108020004682 Single-Stranded DNA Proteins 0.000 description 3
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 3
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 3
• 206010042971 T-cell lymphoma Diseases 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• 230000001464 adherent effect Effects 0.000 description 3
• 125000000217 alkyl group Chemical group 0.000 description 3
• 230000029936 alkylation Effects 0.000 description 3
• KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 230000001004 anti-acetylcholinic effect Effects 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 206010003246 arthritis Diseases 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 238000001574 biopsy Methods 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 238000004422 calculation algorithm Methods 0.000 description 3
• 239000004202 carbamide Substances 0.000 description 3
• 230000004663 cell proliferation Effects 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 239000001913 cellulose Substances 0.000 description 3
• 229920002678 cellulose Polymers 0.000 description 3
• 230000001684 chronic effect Effects 0.000 description 3
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 3
• 239000013599 cloning vector Substances 0.000 description 3
• 239000000356 contaminant Substances 0.000 description 3
• 230000008878 coupling Effects 0.000 description 3
• 238000010168 coupling process Methods 0.000 description 3
• 238000005859 coupling reaction Methods 0.000 description 3
• 230000001086 cytosolic effect Effects 0.000 description 3
• 238000001212 derivatisation Methods 0.000 description 3
• 238000000502 dialysis Methods 0.000 description 3
• 238000002050 diffraction method Methods 0.000 description 3
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 239000000975 dye Substances 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 230000007717 exclusion Effects 0.000 description 3
• 108010055341 glutamyl-glutamic acid Proteins 0.000 description 3
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
• 238000002744 homologous recombination Methods 0.000 description 3
• 230000006801 homologous recombination Effects 0.000 description 3
• 230000007062 hydrolysis Effects 0.000 description 3
• 238000006460 hydrolysis reaction Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 210000000987 immune system Anatomy 0.000 description 3
• 238000002649 immunization Methods 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 238000011081 inoculation Methods 0.000 description 3
• 229940047124 interferons Drugs 0.000 description 3
• 238000004255 ion exchange chromatography Methods 0.000 description 3
• 208000017169 kidney disease Diseases 0.000 description 3
• 201000006370 kidney failure Diseases 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 230000035800 maturation Effects 0.000 description 3
• 229910021645 metal ion Inorganic materials 0.000 description 3
• 230000003278 mimic effect Effects 0.000 description 3
• 210000001322 periplasm Anatomy 0.000 description 3
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
• 239000002953 phosphate buffered saline Substances 0.000 description 3
• 229920002401 polyacrylamide Polymers 0.000 description 3
• 239000002244 precipitate Substances 0.000 description 3
• 238000001556 precipitation Methods 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 238000001742 protein purification Methods 0.000 description 3
• 230000008707 rearrangement Effects 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 238000012340 reverse transcriptase PCR Methods 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 206010039073 rheumatoid arthritis Diseases 0.000 description 3
• 108091092562 ribozyme Proteins 0.000 description 3
• 238000002741 site-directed mutagenesis Methods 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 3
• 230000002194 synthesizing effect Effects 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• PDRJLZDUOULRHE-ZETCQYMHSA-N (2s)-2-amino-3-pyridin-2-ylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=N1 PDRJLZDUOULRHE-ZETCQYMHSA-N 0.000 description 2
• DFZVZEMNPGABKO-ZETCQYMHSA-N (2s)-2-amino-3-pyridin-3-ylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CN=C1 DFZVZEMNPGABKO-ZETCQYMHSA-N 0.000 description 2
• FQFVANSXYKWQOT-ZETCQYMHSA-N (2s)-2-azaniumyl-3-pyridin-4-ylpropanoate Chemical compound OC(=O)[C@@H](N)CC1=CC=NC=C1 FQFVANSXYKWQOT-ZETCQYMHSA-N 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• QEQDLKUMPUDNPG-UHFFFAOYSA-N 2-(7-amino-4-methyl-2-oxochromen-3-yl)acetic acid Chemical compound C1=C(N)C=CC2=C1OC(=O)C(CC(O)=O)=C2C QEQDLKUMPUDNPG-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
• 244000105975 Antidesma platyphyllum Species 0.000 description 2
• 101100437118 Arabidopsis thaliana AUG1 gene Proteins 0.000 description 2
• 101100437119 Arabidopsis thaliana AUG2 gene Proteins 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000972773 Aulopiformes Species 0.000 description 2
• 241001203868 Autographa californica Species 0.000 description 2
• 108050001427 Avidin/streptavidin Proteins 0.000 description 2
• 108010028006 B-Cell Activating Factor Proteins 0.000 description 2
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 244000063299 Bacillus subtilis Species 0.000 description 2
• 102000004506 Blood Proteins Human genes 0.000 description 2
• 108010017384 Blood Proteins Proteins 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• 102000000844 Cell Surface Receptors Human genes 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 208000031404 Chromosome Aberrations Diseases 0.000 description 2
• 108020004394 Complementary RNA Proteins 0.000 description 2
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 101150029662 E1 gene Proteins 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
• 108091029865 Exogenous DNA Proteins 0.000 description 2
• 108060002716 Exonuclease Proteins 0.000 description 2
• 108010067193 Formaldehyde transketolase Proteins 0.000 description 2
• 108090000698 Formate Dehydrogenases Proteins 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
• 108010073807 IgG Receptors Proteins 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 206010053574 Immunoblastic lymphoma Diseases 0.000 description 2
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
• 208000026350 Inborn Genetic disease Diseases 0.000 description 2
• 102100034343 Integrase Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 241000235058 Komagataella pastoris Species 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 2
• 108060001084 Luciferase Proteins 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
• 108090000157 Metallothionein Proteins 0.000 description 2
• 208000010428 Muscle Weakness Diseases 0.000 description 2
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
• 229930193140 Neomycin Natural products 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 2
• 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 2
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
• 108020004485 Nonsense Codon Proteins 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
• 238000012408 PCR amplification Methods 0.000 description 2
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108010067902 Peptide Library Proteins 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
• 102100027330 Phosphoribosylaminoimidazole carboxylase Human genes 0.000 description 2
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
• NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 102000009572 RNA Polymerase II Human genes 0.000 description 2
• 108010009460 RNA Polymerase II Proteins 0.000 description 2
• 108020004518 RNA Probes Proteins 0.000 description 2
• 108020005067 RNA Splice Sites Proteins 0.000 description 2
• 239000003391 RNA probe Substances 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 108090000621 Ribonuclease P Proteins 0.000 description 2
• 102000004167 Ribonuclease P Human genes 0.000 description 2
• 102000006382 Ribonucleases Human genes 0.000 description 2
• 108010083644 Ribonucleases Proteins 0.000 description 2
• 239000002262 Schiff base Substances 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
• 108700005078 Synthetic Genes Proteins 0.000 description 2
• 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 2
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 2
• 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 102000050862 Transmembrane Activator and CAML Interactor Human genes 0.000 description 2
• 108700002109 Transmembrane Activator and CAML Interactor Proteins 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
• 229960004373 acetylcholine Drugs 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000012190 activator Substances 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 125000003282 alkyl amino group Chemical group 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 208000036878 aneuploidy Diseases 0.000 description 2
• 231100001075 aneuploidy Toxicity 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 230000001363 autoimmune Effects 0.000 description 2
• 238000011888 autopsy Methods 0.000 description 2
• 238000000376 autoradiography Methods 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000006037 cell lysis Effects 0.000 description 2
• 238000012412 chemical coupling Methods 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• PMMYEEVYMWASQN-IMJSIDKUSA-N cis-4-Hydroxy-L-proline Chemical compound O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 description 2
• 239000003086 colorant Substances 0.000 description 2
• 230000002860 competitive effect Effects 0.000 description 2
• 239000003184 complementary RNA Substances 0.000 description 2
• 238000004590 computer program Methods 0.000 description 2
• 229940095074 cyclic amp Drugs 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
• 102000003675 cytokine receptors Human genes 0.000 description 2
• 108010057085 cytokine receptors Proteins 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 230000000368 destabilizing effect Effects 0.000 description 2
• 229960002086 dextran Drugs 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
• 238000010494 dissociation reaction Methods 0.000 description 2
• 230000005593 dissociations Effects 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
• 238000002003 electron diffraction Methods 0.000 description 2
• 102000013165 exonuclease Human genes 0.000 description 2
• 230000006539 extracellular acidification Effects 0.000 description 2
• 239000004744 fabric Substances 0.000 description 2
• 238000000684 flow cytometry Methods 0.000 description 2
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 201000003444 follicular lymphoma Diseases 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 208000016361 genetic disease Diseases 0.000 description 2
• 239000010931 gold Substances 0.000 description 2
• 229910052737 gold Inorganic materials 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000012010 growth Effects 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
• 235000009424 haa Nutrition 0.000 description 2
• 230000003394 haemopoietic effect Effects 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• 108010044853 histidine-rich proteins Proteins 0.000 description 2
• 229920001519 homopolymer Polymers 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 230000005847 immunogenicity Effects 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 239000012535 impurity Substances 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 239000007928 intraperitoneal injection Substances 0.000 description 2
• 238000005304 joining Methods 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 101150066555 lacZ gene Proteins 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 108020001756 ligand binding domains Proteins 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 238000004020 luminiscence type Methods 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• OVHQWOXKMOVDJP-UHFFFAOYSA-N melitin Chemical compound OC1C(O)C(O)C(C)OC1OC1C(O)C(OC=2C=C3C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)=C(C=4C=CC(O)=CC=4)O3)=O)=C(O)C=2)OC(C)C1O OVHQWOXKMOVDJP-UHFFFAOYSA-N 0.000 description 2
• CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000013508 migration Methods 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 229960004927 neomycin Drugs 0.000 description 2
• 230000037434 nonsense mutation Effects 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• 239000002751 oligonucleotide probe Substances 0.000 description 2
• 210000003463 organelle Anatomy 0.000 description 2
• 210000002741 palatine tonsil Anatomy 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 230000008506 pathogenesis Effects 0.000 description 2
• 230000007170 pathology Effects 0.000 description 2
• 210000005259 peripheral blood Anatomy 0.000 description 2
• 239000011886 peripheral blood Substances 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• 108010035774 phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 2
• 239000000906 photoactive agent Substances 0.000 description 2
• 229920002704 polyhistidine Polymers 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 230000002797 proteolythic effect Effects 0.000 description 2
• 150000003212 purines Chemical class 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 150000003230 pyrimidines Chemical class 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 238000006722 reduction reaction Methods 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 238000006894 reductive elimination reaction Methods 0.000 description 2
• 201000006845 reticulosarcoma Diseases 0.000 description 2
• 208000029922 reticulum cell sarcoma Diseases 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
• 210000003296 saliva Anatomy 0.000 description 2
• 235000019515 salmon Nutrition 0.000 description 2
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• 238000010254 subcutaneous injection Methods 0.000 description 2
• 239000007929 subcutaneous injection Substances 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 229910052717 sulfur Inorganic materials 0.000 description 2
• 239000011593 sulfur Substances 0.000 description 2
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
• 229940104230 thymidine Drugs 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 210000003437 trachea Anatomy 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 230000001131 transforming effect Effects 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 2
• 210000004291 uterus Anatomy 0.000 description 2
• 239000002699 waste material Substances 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• UJXJZOCXEZPHIE-YFKPBYRVSA-N (2s)-2-(2-hydroxyethylamino)-4-sulfanylbutanoic acid Chemical compound OCCN[C@H](C(O)=O)CCS UJXJZOCXEZPHIE-YFKPBYRVSA-N 0.000 description 1
• JQFLYFRHDIHZFZ-RXMQYKEDSA-N (2s)-3,3-dimethylpyrrolidine-2-carboxylic acid Chemical compound CC1(C)CCN[C@@H]1C(O)=O JQFLYFRHDIHZFZ-RXMQYKEDSA-N 0.000 description 1
• CNPSFBUUYIVHAP-AKGZTFGVSA-N (2s)-3-methylpyrrolidine-2-carboxylic acid Chemical compound CC1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-AKGZTFGVSA-N 0.000 description 1
• FXGZFWDCXQRZKI-VKHMYHEASA-N (2s)-5-amino-2-nitramido-5-oxopentanoic acid Chemical compound NC(=O)CC[C@@H](C(O)=O)N[N+]([O-])=O FXGZFWDCXQRZKI-VKHMYHEASA-N 0.000 description 1
• CNPSFBUUYIVHAP-WHFBIAKZSA-N (2s,3s)-3-methylpyrrolidin-1-ium-2-carboxylate Chemical compound C[C@H]1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-WHFBIAKZSA-N 0.000 description 1
• QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
• QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• 102000007445 2',5'-Oligoadenylate Synthetase Human genes 0.000 description 1
• 108010086241 2',5'-Oligoadenylate Synthetase Proteins 0.000 description 1
• KKTUQAYCCLMNOA-UHFFFAOYSA-N 2,3-diaminobenzoic acid Chemical group NC1=CC=CC(C(O)=O)=C1N KKTUQAYCCLMNOA-UHFFFAOYSA-N 0.000 description 1
• OMGHIGVFLOPEHJ-UHFFFAOYSA-N 2,5-dihydro-1h-pyrrol-1-ium-2-carboxylate Chemical compound OC(=O)C1NCC=C1 OMGHIGVFLOPEHJ-UHFFFAOYSA-N 0.000 description 1
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
• KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• XEVFXAFXZZYFSX-UHFFFAOYSA-N 3-azabicyclo[2.1.1]hexane-4-carboxylic acid Chemical compound C1C2CC1(C(=O)O)NC2 XEVFXAFXZZYFSX-UHFFFAOYSA-N 0.000 description 1
• VGHPYIHJEJAJJZ-UHFFFAOYSA-N 3-hydroxypyrrolidine-2,5-dione;pyrrole-2,5-dione Chemical compound O=C1NC(=O)C=C1.OC1CC(=O)NC1=O VGHPYIHJEJAJJZ-UHFFFAOYSA-N 0.000 description 1
• GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 1
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
• CKTSBUTUHBMZGZ-ULQXZJNLSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidin-2-one Chemical compound O=C1N=C(N)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-ULQXZJNLSA-N 0.000 description 1
• 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
• HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
• XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 1
• 108020005029 5' Flanking Region Proteins 0.000 description 1
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
• LUCHPKXVUGJYGU-XLPZGREQSA-N 5-methyl-2'-deoxycytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 LUCHPKXVUGJYGU-XLPZGREQSA-N 0.000 description 1
• FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical group NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
• 101150096273 ADE2 gene Proteins 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 241000228431 Acremonium chrysogenum Species 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 208000009746 Adult T-Cell Leukemia-Lymphoma Diseases 0.000 description 1
• 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 description 1
• 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 108010025188 Alcohol oxidase Proteins 0.000 description 1
• 102100036826 Aldehyde oxidase Human genes 0.000 description 1
• 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 206010001881 Alveolar proteinosis Diseases 0.000 description 1
• 229920000856 Amylose Polymers 0.000 description 1
• 206010073478 Anaplastic large-cell lymphoma Diseases 0.000 description 1
• 241000024188 Andala Species 0.000 description 1
• 206010002412 Angiocentric lymphomas Diseases 0.000 description 1
• 208000006820 Arthralgia Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 208000037157 Azotemia Diseases 0.000 description 1
• WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
• 108700040077 Baculovirus p10 Proteins 0.000 description 1
• 102100029516 Basic salivary proline-rich protein 1 Human genes 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 235000018185 Betula X alpestris Nutrition 0.000 description 1
• 235000018212 Betula X uliginosa Nutrition 0.000 description 1
• 241000212384 Bifora Species 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
• ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 241000222128 Candida maltosa Species 0.000 description 1
• 241000282461 Canis lupus Species 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• 241000238586 Cirripedia Species 0.000 description 1
• 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 239000004971 Cross linker Substances 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• 101710112752 Cytotoxin Proteins 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 206010011878 Deafness Diseases 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 208000016192 Demyelinating disease Diseases 0.000 description 1
• 206010012305 Demyelination Diseases 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 102100040606 Dermatan-sulfate epimerase Human genes 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 206010014561 Emphysema Diseases 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 102000004533 Endonucleases Human genes 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 208000002460 Enteropathy-Associated T-Cell Lymphoma Diseases 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
• 208000036566 Erythroleukaemia Diseases 0.000 description 1
• 108010075944 Erythropoietin Receptors Proteins 0.000 description 1
• 102100036509 Erythropoietin receptor Human genes 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 206010015548 Euthanasia Diseases 0.000 description 1
• XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
• 108010020195 FLAG peptide Proteins 0.000 description 1
• 108010021468 Fc gamma receptor IIA Proteins 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• 101150094690 GAL1 gene Proteins 0.000 description 1
• 102100028501 Galanin peptides Human genes 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 208000002966 Giant Cell Tumor of Bone Diseases 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• 102000000340 Glucosyltransferases Human genes 0.000 description 1
• 108010055629 Glucosyltransferases Proteins 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 108010053070 Glutathione Disulfide Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 102100020948 Growth hormone receptor Human genes 0.000 description 1
• 101150069554 HIS4 gene Proteins 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 102100027685 Hemoglobin subunit alpha Human genes 0.000 description 1
• 108091005902 Hemoglobin subunit alpha Proteins 0.000 description 1
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
• 101001125486 Homo sapiens Basic salivary proline-rich protein 1 Proteins 0.000 description 1
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
• 101000816698 Homo sapiens Dermatan-sulfate epimerase Proteins 0.000 description 1
• 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 description 1
• 101000741885 Homo sapiens Protection of telomeres protein 1 Proteins 0.000 description 1
• YZJSUQQZGCHHNQ-UHFFFAOYSA-N Homoglutamine Chemical compound OC(=O)C(N)CCCC(N)=O YZJSUQQZGCHHNQ-UHFFFAOYSA-N 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 241001619348 Idris Species 0.000 description 1
• 235000003332 Ilex aquifolium Nutrition 0.000 description 1
• 241000209027 Ilex aquifolium Species 0.000 description 1
• 108010058683 Immobilized Proteins Proteins 0.000 description 1
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 108010060231 Insect Proteins Proteins 0.000 description 1
• 101710203526 Integrase Proteins 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 244000285963 Kluyveromyces fragilis Species 0.000 description 1
• 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
• 241001138401 Kluyveromyces lactis Species 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
• DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 description 1
• KKJQZEWNZXRJFG-UHFFFAOYSA-N L-trans-4-Methyl-2-pyrrolidinecarboxylic acid Chemical compound CC1CNC(C(O)=O)C1 KKJQZEWNZXRJFG-UHFFFAOYSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 208000032004 Large-Cell Anaplastic Lymphoma Diseases 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 108010047357 Luminescent Proteins Proteins 0.000 description 1
• 102000006830 Luminescent Proteins Human genes 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 101710141347 Major envelope glycoprotein Proteins 0.000 description 1
• 208000025205 Mantle-Cell Lymphoma Diseases 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
• 101100243377 Mus musculus Pepd gene Proteins 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 102000047918 Myelin Basic Human genes 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 102000055324 Myelin Proteolipid Human genes 0.000 description 1
• 101710107068 Myelin basic protein Proteins 0.000 description 1
• 101710094913 Myelin proteolipid protein Proteins 0.000 description 1
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
• 102100030856 Myoglobin Human genes 0.000 description 1
• 108010062374 Myoglobin Proteins 0.000 description 1
• 108060008487 Myosin Proteins 0.000 description 1
• 102000003505 Myosin Human genes 0.000 description 1
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
• 238000011887 Necropsy Methods 0.000 description 1
• 241000221960 Neurospora Species 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 241000320412 Ogataea angusta Species 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 238000010222 PCR analysis Methods 0.000 description 1
• 229920001734 PEG propionaldehyde Polymers 0.000 description 1
• 101150029183 PEP4 gene Proteins 0.000 description 1
• 101150012394 PHO5 gene Proteins 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 description 1
• 208000027190 Peripheral T-cell lymphomas Diseases 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• 108010081690 Pertussis Toxin Proteins 0.000 description 1
• 108010053210 Phycocyanin Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 241000235648 Pichia Species 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 101710182846 Polyhedrin Proteins 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
• 102100038745 Protection of telomeres protein 1 Human genes 0.000 description 1
• 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
• 206010037601 Pyelonephritis chronic Diseases 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 238000002123 RNA extraction Methods 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 206010038486 Renal neoplasms Diseases 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 241000219061 Rheum Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 101150014136 SUC2 gene Proteins 0.000 description 1
• 108010077895 Sarcosine Proteins 0.000 description 1
• 150000004753 Schiff bases Chemical class 0.000 description 1
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
• 206010040070 Septic Shock Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 108700025832 Serum Response Element Proteins 0.000 description 1
• 244000000231 Sesamum indicum Species 0.000 description 1
• 235000003434 Sesamum indicum Nutrition 0.000 description 1
• 239000000877 Sex Attractant Substances 0.000 description 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
• 108010068542 Somatotropin Receptors Proteins 0.000 description 1
• 101800001707 Spacer peptide Proteins 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
• 208000031672 T-Cell Peripheral Lymphoma Diseases 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 102100029337 Thyrotropin receptor Human genes 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• 241000255993 Trichoplusia ni Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 1
• 101710178300 Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 description 1
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
• 244000301083 Ustilago maydis Species 0.000 description 1
• 235000015919 Ustilago maydis Nutrition 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 206010047115 Vasculitis Diseases 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 241000269370 Xenopus <genus> Species 0.000 description 1
• PCBMGUSDYHYVBQ-SOOFDHNKSA-N [4-amino-2-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-imidazol-5-yl]phosphonic acid Chemical compound P(=O)(O)(O)C=1N=C(NC1N)C1[C@H](O)[C@H](O)[C@H](O1)CO PCBMGUSDYHYVBQ-SOOFDHNKSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 108020002494 acetyltransferase Proteins 0.000 description 1
• 102000005421 acetyltransferase Human genes 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 208000021841 acute erythroid leukemia Diseases 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 230000001919 adrenal effect Effects 0.000 description 1
• 210000004100 adrenal gland Anatomy 0.000 description 1
• 238000005377 adsorption chromatography Methods 0.000 description 1
• 201000006966 adult T-cell leukemia Diseases 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 230000000172 allergic effect Effects 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 238000003277 amino acid sequence analysis Methods 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 206010002022 amyloidosis Diseases 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000003367 anti-collagen effect Effects 0.000 description 1
• 230000003172 anti-dna Effects 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 208000037908 antibody-mediated disorder Diseases 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 102000025171 antigen binding proteins Human genes 0.000 description 1
• 108091000831 antigen binding proteins Proteins 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000012736 aqueous medium Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 125000004104 aryloxy group Chemical group 0.000 description 1
• 229920001718 aryloxy-PEG Polymers 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 239000012911 assay medium Substances 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 208000010668 atopic eczema Diseases 0.000 description 1
• 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
• 239000013602 bacteriophage vector Substances 0.000 description 1
• 238000013142 basic testing Methods 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 238000011953 bioanalysis Methods 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000029918 bioluminescence Effects 0.000 description 1
• 238000005415 bioluminescence Methods 0.000 description 1
• 229920001743 bis-succinimidyl carbonate PEG Polymers 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 238000004820 blood count Methods 0.000 description 1
• 229910052796 boron Inorganic materials 0.000 description 1
• 150000001639 boron compounds Chemical class 0.000 description 1
• LRJRPHROCLHMHK-UHFFFAOYSA-N boron;n,n-dimethylmethanamine Chemical compound [B].CN(C)C LRJRPHROCLHMHK-UHFFFAOYSA-N 0.000 description 1
• RJTANRZEWTUVMA-UHFFFAOYSA-N boron;n-methylmethanamine Chemical compound [B].CNC RJTANRZEWTUVMA-UHFFFAOYSA-N 0.000 description 1
• NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical compound [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 description 1
• 238000009395 breeding Methods 0.000 description 1
• 230000001488 breeding effect Effects 0.000 description 1
• 206010006451 bronchitis Diseases 0.000 description 1
• 229950004398 broxuridine Drugs 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 239000008366 buffered solution Substances 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 108091000084 calmodulin binding Proteins 0.000 description 1
• 102000028861 calmodulin binding Human genes 0.000 description 1
• 150000001718 carbodiimides Chemical class 0.000 description 1
• 125000000837 carbohydrate group Chemical group 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 108091092356 cellular DNA Proteins 0.000 description 1
• 230000008614 cellular interaction Effects 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 230000003196 chaotropic effect Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 229920001429 chelating resin Polymers 0.000 description 1
• 238000002038 chemiluminescence detection Methods 0.000 description 1
• 239000005081 chemiluminescent agent Substances 0.000 description 1
• 229940044683 chemotherapy drug Drugs 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 201000006368 chronic pyelonephritis Diseases 0.000 description 1
• 238000002983 circular dichroism Methods 0.000 description 1
• 238000009535 clinical urine test Methods 0.000 description 1
• 238000012411 cloning technique Methods 0.000 description 1
• 238000003501 co-culture Methods 0.000 description 1
• 229940047120 colony stimulating factors Drugs 0.000 description 1
• 238000007398 colorimetric assay Methods 0.000 description 1
• 230000024203 complement activation Effects 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 230000001268 conjugating effect Effects 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000013601 cosmid vector Substances 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 239000002619 cytotoxin Substances 0.000 description 1
• 231100000895 deafness Toxicity 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
• 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 238000010612 desalination reaction Methods 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 238000001085 differential centrifugation Methods 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
• 229960002986 dinoprostone Drugs 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
• 229940043264 dodecyl sulfate Drugs 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 150000002061 ecdysteroids Chemical class 0.000 description 1
• 210000003162 effector t lymphocyte Anatomy 0.000 description 1
• 230000005684 electric field Effects 0.000 description 1
• 238000002567 electromyography Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 210000002308 embryonic cell Anatomy 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 230000003511 endothelial effect Effects 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 108010092809 exonuclease Bal 31 Proteins 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 238000001215 fluorescent labelling Methods 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 231100000118 genetic alteration Toxicity 0.000 description 1
• 230000004077 genetic alteration Effects 0.000 description 1
• 238000012252 genetic analysis Methods 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 108010046301 glucose peroxidase Proteins 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 102000035122 glycosylated proteins Human genes 0.000 description 1
• 108091005608 glycosylated proteins Proteins 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 229910052736 halogen Inorganic materials 0.000 description 1
• 150000002367 halogens Chemical class 0.000 description 1
• 208000016354 hearing loss disease Diseases 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 108060003552 hemocyanin Proteins 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 210000005161 hepatic lobe Anatomy 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 235000012907 honey Nutrition 0.000 description 1
• 102000055229 human IL4 Human genes 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 238000002169 hydrotherapy Methods 0.000 description 1
• MWFRVMDVLYIXJF-BYPYZUCNSA-N hydroxyethylcysteine Chemical compound OC(=O)[C@@H](N)CSCCO MWFRVMDVLYIXJF-BYPYZUCNSA-N 0.000 description 1
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
• 208000013403 hyperactivity Diseases 0.000 description 1
• 150000002466 imines Chemical class 0.000 description 1
• 108091006058 immobilized fusion proteins Proteins 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 208000024120 immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis Diseases 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 229940096397 interleukin-8 Drugs 0.000 description 1
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 239000001573 invertase Substances 0.000 description 1
• 235000011073 invertase Nutrition 0.000 description 1
• 230000037427 ion transport Effects 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
• HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 201000011649 lymphoblastic lymphoma Diseases 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 229920001427 mPEG Polymers 0.000 description 1
• 229960003511 macrogol Drugs 0.000 description 1
• 208000032345 macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss Diseases 0.000 description 1
• 238000007885 magnetic separation Methods 0.000 description 1
• 230000010311 mammalian development Effects 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 201000007924 marginal zone B-cell lymphoma Diseases 0.000 description 1
• 208000021937 marginal zone lymphoma Diseases 0.000 description 1
• 210000003519 mature b lymphocyte Anatomy 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 239000004570 mortar (masonry) Substances 0.000 description 1
• 230000036473 myasthenia Effects 0.000 description 1
• 201000005962 mycosis fungoides Diseases 0.000 description 1
• 210000005012 myelin Anatomy 0.000 description 1
• 230000010807 negative regulation of binding Effects 0.000 description 1
• 201000008383 nephritis Diseases 0.000 description 1
• 230000002232 neuromuscular Effects 0.000 description 1
• 208000013315 neuromuscular junction disease Diseases 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 208000002886 neutrophil immunodeficiency syndrome Diseases 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 210000000287 oocyte Anatomy 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 238000012261 overproduction Methods 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 238000007248 oxidative elimination reaction Methods 0.000 description 1
• YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
• 150000002924 oxiranes Chemical class 0.000 description 1
• 230000020477 pH reduction Effects 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000005298 paramagnetic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
• 230000007030 peptide scission Effects 0.000 description 1
• 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 101150009573 phoA gene Proteins 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 108010031345 placental alkaline phosphatase Proteins 0.000 description 1
• 210000005059 placental tissue Anatomy 0.000 description 1
• 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 1
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 235000020004 porter Nutrition 0.000 description 1
• 238000002600 positron emission tomography Methods 0.000 description 1
• 230000001323 posttranslational effect Effects 0.000 description 1
• 229940124606 potential therapeutic agent Drugs 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 230000001376 precipitating effect Effects 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 238000002731 protein assay Methods 0.000 description 1
• 108020001580 protein domains Proteins 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 201000003489 pulmonary alveolar proteinosis Diseases 0.000 description 1
• 230000000541 pulsatile effect Effects 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
• 230000001698 pyrogenic effect Effects 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 101150079601 recA gene Proteins 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000026267 regulation of growth Effects 0.000 description 1
• 230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 210000001995 reticulocyte Anatomy 0.000 description 1
• 108010038196 saccharide-binding proteins Proteins 0.000 description 1
• 210000003079 salivary gland Anatomy 0.000 description 1
• 238000013391 scatchard analysis Methods 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• 150000003335 secondary amines Chemical class 0.000 description 1
• 239000013049 sediment Substances 0.000 description 1
• JRPHGDYSKGJTKZ-UHFFFAOYSA-K selenophosphate Chemical compound [O-]P([O-])([O-])=[Se] JRPHGDYSKGJTKZ-UHFFFAOYSA-K 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 230000036303 septic shock Effects 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 239000011550 stock solution Substances 0.000 description 1
• 108010018381 streptavidin-binding peptide Proteins 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• NPDBDJFLKKQMCM-UHFFFAOYSA-N tert-butylglycine Chemical compound CC(C)(C)C(N)C(O)=O NPDBDJFLKKQMCM-UHFFFAOYSA-N 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 108040006218 thyroid-stimulating hormone receptor activity proteins Proteins 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 229920001733 tresyl monomethoxy PEG Polymers 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 239000000439 tumor marker Substances 0.000 description 1
• 102000042287 type II cytokine receptor family Human genes 0.000 description 1
• 108091052254 type II cytokine receptor family Proteins 0.000 description 1
• 230000005951 type IV hypersensitivity Effects 0.000 description 1
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• WQAJKOXBERTWBK-UHFFFAOYSA-N verdine Natural products CC1CNC2C(C1)OC3(CCC4C5CCC6(O)CC(O)CC(O)C6(C)C5C(=O)C4=C3C)C2C WQAJKOXBERTWBK-UHFFFAOYSA-N 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1